NGM BIOPHARMACEUTICALS

Serial Number 97341658
606

Registration Progress

Application Filed
Mar 31, 2022
Under Examination
May 30, 2023
Approved for Publication
Apr 4, 2023
Published for Opposition
Apr 4, 2023
Registered

Basic Information

Serial Number
97341658
Filing Date
March 31, 2022
Published for Opposition
April 4, 2023
Abandonment Date
January 1, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jan 1, 2024
Classes
005 042 044

Rights Holder

NGM Biopharmaceuticals, Inc.

03
Address
333 Oyster Point Boulevard
South San Francisco, CA 94080

Ownership History

NGM Biopharmaceuticals, Inc.

Original Applicant
03
South San Francisco, CA

NGM Biopharmaceuticals, Inc.

Owner at Publication
03
South San Francisco, CA

Legal Representation

Attorney
Ilene B. Tannen

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

16 events
Date Code Type Description
Jan 2, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jan 1, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
May 30, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 4, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 4, 2023 PUBO A PUBLISHED FOR OPPOSITION
Mar 15, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 1, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 2, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 1, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 1, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 9, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 9, 2022 GNRT F NON-FINAL ACTION E-MAILED
Aug 9, 2022 CNRT R NON-FINAL ACTION WRITTEN
Aug 4, 2022 DOCK D ASSIGNED TO EXAMINER
Apr 6, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 4, 2022 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Class 042
Class 044

Classification

International Classes
005 042 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOPHARMACEUTICALS"